Department of Anaesthesia, Copenhagen University Hospital, Frederiksberg
Frederiksberg, 2000, Denmark
NCT Number: NCT01470391
The aim of this study is to investigate the efficacy of the Adductor-Canal-Blockade versus the Femoral Nerve Block on muscle strength, pain and mobilization after total knee arthroplasty. We hypothesize that the Adductor-Canal-Blockade has the same effect on pain and morphine consumption as the Femoral Nerve Block, but without the same reduction in quadriceps muscle strength.
Looking for future studies?
Notify Me50 year–85 year
All sexes
Interventional
Not applicable
Frederiksberg, 2000, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
US-guided Adductor-Canal-Blockade with Ropivacaine
US-guided Femoral Nerve Block with Ropivacaine
Time frame: 24 h postoperatively
Time frame: 24 h postoperatively
Time frame: 2-24 hours
0-100 mm at a visual analogue scale (VAS), calculated as the area under the curve for the interval 2-24 hours postoperatively.
Time frame: 2-24 hours
0-100 mm at a visual analogue scale (VAS), calculated as the area under the curve for the interval 2-24 hours postoperatively.
Time frame: 0-24 hours
Time frame: 2-24 hours
Time frame: 0-24 hours
Time frame: 2-24 hours
Time frame: 0-24 hours
Number of patients recieveing zofran postoperatively
Time frame: 24 hours
Rigshospitalet, Denmark
Other
"A Comparison of the Efficacy of the Adductor-Canal-Blockade Versus the Femoral Nerve Block on Muscle Strength, Pain and Mobilization After Total Knee Arthroplasty: a Randomized Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06460350
Neurologic Manifestations, Pain
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06966011
Agnosia, Nervous System Diseases
Konya, Turkey (Türkiye)
View Trial DetailsNCT07375472
Neurologic Manifestations, Pain
Osmaniye, Turkey (Türkiye)
View Trial DetailsNCT06908837
Multimodal Analgesic Approach, Neurologic Manifestations
Silkeborg, Denmark Central Region, Denmark
View Trial Details